Early warning signs of potential drug resistance in schistosomiasis parasite revealed

Scientists have discovered genetic markers in Schistosoma mansoni parasites that indicate potential resistance to praziquantel, the primary treatment for schistosomiasis. This genomic surveillance provides a critical early warning for global disease control programs.
Why it matters
As praziquantel is the only available treatment for this widespread neglected tropical disease, monitoring resistance is vital for public health.
edited by Sadie Harley , reviewed by Andrew Zinin
The article provides a factual summary of medical research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in